Oral Health Group
News

Dentsply Sirona Extends the Lucitone Digital Print Denture System with New Material Indications and Planned Print Platform Validations for Asiga and SprintRay

September 24, 2021
by Dentsply Sirona


New denture tooth materials and indications significantly expand the production capabilities of the Lucitone Digital Print Denture System enabling the production of nearly all full arch denture types. Additionally, Dentsply Sirona announces the planned validation of Asiga and SprintRay 3D printers for Lucitone Digital Print Denture later in 2021. Both of these announcements further enable the continued digital transformation in dental laboratories worldwide.

Dentsply Sirona announced today four expansions of the Lucitone Digital Print Denture System, adding momentum to the digital transformation of the dental laboratory industry. Three of these expansions are for the digital production of custom tooth arches and segments, including the addition of Lucitone Digital Value 3D Economy Tooth and Trial Placement resin; DS Multilayer PMMA Discs for milling premium denture teeth; and the planned 2022 release of Lucitone Digital IPN, a printed premium denture tooth material. Later in 2021, planned printer validations for the Lucitone Digital Print Denture System will include Asiga Max UV and Pro 4K and SprintRay Pro 95 and Pro 55 series printers. Lucitone Digital Value and DS Multilayer PMMA denture tooth workflows are validated and immediately available for Carbon M-Series printers.

These important updates provide dental laboratories greater flexibility to fully digitize their denture production with the superior strength Lucitone Digital Print Denture System. The forthcoming validation of Asiga and SprintRay printers will enable more labs to benefit from the enhanced capacity, throughput and simplicity of Dentsply Sirona printed dentures, delivering repeatable and precise results.

“This collaboration with Dentsply Sirona continues Asiga’s open-system vision to bring best-in-class, highly accurate, highly affordable printing technology to the dental industry,” said Justin Elsey, founder and managing director of Asiga. “Together, we are opening access to dental labs and their patients to a superior combination of printed denture materials and printer accuracy and consistency.”

“At SprintRay, we strive to build products that work together to create opportunity for collaboration, innovation and, most importantly, outstanding clinical results,” said Amir Mansouri, CEO and Co-Founder. “Our cooperation with Dentsply Sirona embodies this vision by bringing together high quality products to deliver first-class service to patients all the while empowering improved efficiency and production for dental practices and labs everywhere.”

“Until the introduction of the Lucitone Digital Print Denture System, printed dentures were not a viable option for dental labs,” shared Julie Mroziak, Vice President, Dentsply Sirona Digital Lab and Preventive Solutions. “Now, with the planned validation of Asiga and SprintRay printers for Lucitone Digital Print Denture, and more material options, labs can begin transitioning from analog denture procedures to the more efficient, digitally printed denture workflows. The digital acceleration of the removable lab industry is truly exciting, and a win-win for the lab, dentist and patient experience.”

With the versatile Dentsply Sirona Multilayer PMMA 98mm disc range, dental laboratories now can mill custom tooth arches or segments to digitally manage more challenging removable cases, including reduced vertical and class II and class III occlusions. The disc product line provides comprehensive shade choices, seventeen in total, three-disc thicknesses, and delivers premium tooth esthetics.

Additionally, the dual-use Lucitone Digital Value 3D Economy Tooth & Trial Placement resin allows for printing try-in appliances and economy tooth arches and segments. This ready-to-print tooth material balances economic durability and esthetics. The material is available in six shades and suitable for all clinical classifications of full-arch denture cases.

The planned 2022 release of Lucitone Digital IPN will be Dentsply Sirona’s first printed premium denture tooth solution. This new material is expected to have exceptional wear characteristics and include sixteen shades plus bleach options. The Lucitone Digital IPN material will remove all barriers for dental laboratories’ migration to digital denture workflows.

The clinical and laboratory workflows are simple and easy for rapid integration. With these anticipated printer validations and material launches, laboratories of all sizes can better meet increasing volume demands, achieve greater profitability, and provide patients with an experience and denture that will make them smile in partnership with their dentist.

Carbon is a registered trademark of Carbon, Inc.

SprintRay is a registered trademark of SprintRay, Inc.

Asiga is a registered trademark of Asiga.


ABOUT DENTSPLY SIRONA                                                                                   

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters are located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.